Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - esketamine hydrochloride, quantity: 32.3 mg (equivalent: esketamine, qty 28 mg) - spray, nasal - excipient ingredients: disodium edetate; citric acid monohydrate; water for injections; sodium hydroxide - spravato is indicated for treatment resistant depression (major depressive disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current moderate to severe depressive episode).,spravato is to be initiated in conjunction with a newly initiated oral antidepressant.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: glycerol; disodium edetate; phenethyl alcohol; purified water; carmellose sodium; microcrystalline cellulose; polysorbate 80; benzalkonium chloride - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: disodium edetate; purified water; glycerol; microcrystalline cellulose; polysorbate 80; phenethyl alcohol; benzalkonium chloride; carmellose sodium - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - mometasone furoate, quantity: 50 microgram/actuation - spray, suspension - excipient ingredients: benzalkonium chloride; citric acid monohydrate; sodium citrate dihydrate; dispersible cellulose; glycerol; citric acid; polysorbate 80; purified water - uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis in adults, adolescents and children between the ages of 3 and 11 years. uniclar aqueous nasal spray 0.05% is also indicated for the treatment of nasal polyps in adult patients 18 years of age and older. uniclar aqueous nasal spray 0.05% is indicated for the treatment of symptoms associated with acute rhinosinusitis in patients 12 years of age and older without signs or symptoms of severe bacterial infection.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - ciclesonide, quantity: 50 microgram/actuation - spray, nasal - excipient ingredients: potassium sorbate; hypromellose; purified water; microcrystalline cellulose; disodium edetate; carmellose sodium; hydrochloric acid; nitrogen - omnaris nasal spray is indicated for: the treatment of seasonal allergic rhinitis in adults and children 6 years of age and older; and for the treatment of perennial allergic rhinitis in adults and adolescents 12 years of age and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan, quantity: 100 mg/ml - spray, solution - excipient ingredients: sulfuric acid; monobasic potassium phosphate; purified water; dibasic sodium phosphate; sodium hydroxide - imigran s nasal spray is indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of imigran s in the treatment of basilar or hemiplegic migraine.

Malta - English - Medicines Authority

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - azelastine hydrochloride - nasal spray, solution - azelastine hydrochloride 1 mg - nasal preparations

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - sumatriptan, quantity: 200 mg/ml - spray, solution - excipient ingredients: dibasic sodium phosphate; purified water; monobasic potassium phosphate; sulfuric acid; sodium hydroxide - imigran nasal spray is indicated for the acute relief of migraine attacks with or without aura. there is no information available on the use of imigran in the treatment of basilar or hemiplegic migraine.

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.1 mg/ml (equivalent: desmopressin, qty 0.089 mg/ml) - spray, solution - excipient ingredients: dibasic sodium phosphate dihydrate; citric acid monohydrate; sodium chloride; purified water; benzalkonium chloride - diabetes insipidus:the treatment of adh-sensitive cranial diabetes insipidus, including treatment of post-hypophysectomy polydipsia and polyuria.,nocturnal enuresis: minirin nasal spray is indicated for the symptomatic treatment of primary nocturnal enuresis in patients who have normal ability to concentrate urine. minirin nasal spray should be used only in patients who are refractory to the enuresis alarm or in patients in whom enuresis alarm is contraindicated or inappropriate, and where the oral administration of desmopressin is not feasible.,renal concentrating capacity: by intranasal administration to adults and children as a diagnostic test to establish renal concentrating capacity.

Malta - English - Medicines Authority

mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - azelastine hydrochloride, fluticasone propionate - nasal spray, suspension - azelastine hydrochloride 137 µg/spray fluticasone propionate 50 µg/spray - nasal preparations